Last reviewed · How we verify
short-course antibiotic treatment
short-course antibiotic treatment is a Small molecule drug developed by Rabin Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | short-course antibiotic treatment |
|---|---|
| Sponsor | Rabin Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP (PHASE4)
- Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
- Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis (NA)
- Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever (NA)
- Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial (PHASE2)
- Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial (NA)
- Preventive Strategies for Early and Late Complications of Leptospirosis (PHASE2)
- STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- short-course antibiotic treatment CI brief — competitive landscape report
- short-course antibiotic treatment updates RSS · CI watch RSS
- Rabin Medical Center portfolio CI
Frequently asked questions about short-course antibiotic treatment
What is short-course antibiotic treatment?
short-course antibiotic treatment is a Small molecule drug developed by Rabin Medical Center.
Who makes short-course antibiotic treatment?
short-course antibiotic treatment is developed by Rabin Medical Center (see full Rabin Medical Center pipeline at /company/rabin-medical-center).
What development phase is short-course antibiotic treatment in?
short-course antibiotic treatment is in Phase 1.